Norouzi Mahnaz, Shafiei Mohammad, Abdollahi Zeinab, Miar Paniz, Galehdari Hamid, Emami Mohammad Hasan, Zeinalian Mehrdad, Tabatabaiefar Mohammad Amin
Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Front Oncol. 2021 Jun 7;11:648649. doi: 10.3389/fonc.2021.648649. eCollection 2021.
Familial cancers comprise a considerable distribution of colorectal cancers (CRCs), of which only about 5% occurs through well-established hereditary syndromes. It has been demonstrated that deleterious variants at the newly identified cancer-predisposing genes could describe the etiology of undefined familial cancers.
The present study aimed to identify the genetic etiology in a 32-year-old man with early onset familial CRC employing several molecular diagnostic techniques. DNA was extracted from tumoral and normal formalin-fixed-paraffin-embedded (FFPE) blocks, and microsatellite instability (MSI) was evaluated. Immunohistochemistry staining of MMR proteins was performed on tumoral FFPE blocks. Next-generation sequencing (NGS), multiplex ligation-dependent amplification (MLPA) assay, and Sanger sequencing were applied on the genomic DNA extracted from peripheral blood. Data analysis was performed using bioinformatics tools. Genetic variants interpretation was based on ACMG.
MSI analysis indicated MSI-H phenotype, and IHC staining proved no expressions of MSH2 and MSH6 proteins. MLPA and NGS data showed no pathogenic variants in MMR genes. Further analysis of NGS data revealed a candidate frameshift variant (p.R389Efs*3), which was validated with Sanger sequencing. The variant was interpreted as pathogenic since it met the criteria based on the ACMG guideline including very strong (PVS1), strong (PS3), and moderate (PM2).
is a DNA helicase participating in DNA repair pathways to sustain genomic stability. deficient function may contribute to CRC development that is valuable for further investigation as a candidate gene in hereditary cancer syndrome diagnosis.
家族性癌症在结直肠癌(CRC)中占相当比例,其中只有约5%是通过已明确的遗传综合征发生的。已证明新发现的癌症易感基因中的有害变异可解释不明原因的家族性癌症的病因。
本研究旨在采用多种分子诊断技术,确定一名32岁早发性家族性CRC男性的遗传病因。从肿瘤和正常福尔马林固定石蜡包埋(FFPE)组织块中提取DNA,并评估微卫星不稳定性(MSI)。对肿瘤FFPE组织块进行错配修复(MMR)蛋白的免疫组织化学染色。对外周血提取的基因组DNA应用二代测序(NGS)、多重连接依赖探针扩增(MLPA)分析和桑格测序。使用生物信息学工具进行数据分析。遗传变异的解释基于美国医学遗传学与基因组学学会(ACMG)标准。
MSI分析显示为MSI-H表型,免疫组化染色证明MSH2和MSH6蛋白无表达。MLPA和NGS数据显示MMR基因无致病变异。对NGS数据的进一步分析发现一个候选移码变异(p.R389Efs*3),经桑格测序验证。该变异被解释为致病,因为它符合基于ACMG指南的标准,包括非常强(PVS1)、强(PS3)和中等(PM2)。
是一种参与DNA修复途径以维持基因组稳定性的DNA解旋酶。 功能缺陷可能导致CRC的发生,作为遗传性癌症综合征诊断的候选基因,对进一步研究具有重要价值。